1.Ferro JM, Fonseca AC. Infective endocarditis. Handb Clin Neurol. 2014; 119:75–91.
2.Dunne B, Marr T, Kim D, Andrews D, Edwards M, Merry C, Larbalestier R. Infective endocarditis. Heart Lung Circ. 2014; 23(7):628–35.
3.Tubiana S, Blotière PO, Hoen B, Lesclous P, Millot S, Rudant J, et al.Duval X. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. Bmj. 2017; 358:j3776..
4.Chen PC, Tung YC, Wu PW, Wu LS, Lin YS, Chang CJ, et al. Dental Procedures and the Risk of Infective Endocarditis. Medicine. 2015; 94(43):1826.
5.Delahaye F, M’Hammedi A, Guerpillon B, de Gevigney G, Boibieux A, Dauwalder O, et al.Vandenesch F. Systematic Search for Present and Potential Portals of Entry for Infective Endocarditis. J Am Coll Cardiol. 2016; 67(2):151–8.
6.Parahitiyawa NB, Jin LJ, Leung WK, Yam WC, Samaranayake LP. Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev. 2009; 22(1):46–64.
7.Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21;36(44):3075–3128. doi: 10.1093/eurheartj/ehv319.
8.Segura-Egea JJ, Gould K, Sen BH. Antibiotics in Endodontics: a review. Int Endod J. 2017; 50(12):1169–84.
9.Wang R, Kaplan A, Guo L, Shi W, Zhou X, Lux R, He X. The influence of iron availability on human salivary microbial community composition. Microb Ecol. 2012; 64(1):152–61.
10.Cassat James e, Skaar Eric p. Iron in Infection and Immunity. Cell Host Microbe. 2013 May 15;13(5):509–519.
11.Verbon EH, Trapet PL, Stringlis IA, Kruijs S, Bakker PAHM, Pieterse CMJ. Iron and Immunity. Annu Rev Phytopathol. 2017; doi: 10.1146/annurev-phyto–080516–035537.
12.Scott D, Chan EC, Siboo R. Iron acquisition by oral hemolytic spirochetes: isolation of a hemin-binding protein and identification of iron reductase activity. Can J Microbiol. 1996; 42(10):1072–9.
13.Rhodes ER, Menke S, Shoemaker C, Tomaras AP, McGillivary G, Actis LA. Iron acquisition in the dental pathogen Actinobacillus actinomycetemcomitans: what does it use as a source and how does it get this essential metal? Biometals. 2007; 20(3–4):365–77.
14.Grenier D, Tanabe S. Transferrin as a source of iron for Campylobacter rectus. J Oral Microbiol. 2011 Jan 12;3; doi: 10.3402/jom.v3i0.5660.
15.Moon JH, Herr Y, Kim SW, Lee JY. In vitro activity of deferoxamine against Porphyromonas gingivalis. FEMS Microbiol Lett. 2011; 323(1):61–7.
16.Dashper SG, Ang CS, Veith PD, Mitchell HL, Lo AW, Seers CA, et al. Response of Porphyromonas gingivalis to heme limitation in continuous culture. J Bacteriol. 2009; 191(3):1044–55.
17.Wilks A, Ikeda-Saito M. Heme utilization by pathogenic bacteria: not all pathways lead to biliverdin. Acc Chem Res. 2014; 47(8):2291–8.
18.Bruyneel B, Vande Woestyne M, Verstraete W. Lactic acid bacteria: Micro-organisms able to grow in the absence of available iron and copper. Biotechnol Lett. 1989; 11(6):401–6.
19. Hadfield J, David S. A bit of a mouthful. Nat Rev Microbiol. 2016; doi: 10.1038/nrmicro.
20.Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. The Lancet. 2016; 387(10021):907–16.
21.Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014; 123(5):615.
22.Balarajan Y, Ramakrishnan U, Özaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and middle-income countries. The Lancet. 2011; 378(9809):2123–35.
23.Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015; 372(19):1832–43.
24.Jagannathan N, Thiruvengadam C, Ramani P, Premkumar P, Natesan A, Sherlin HJ. Salivary ferritin as a predictive marker of iron deficiency anemia in children. J Clin Pediatr Dent. 2012; 37(1):25.
25.Mishra OP, Agarwal KN, Agarwal RMD. Salivary Iron Status in Children with Iron Deficiency and Iron overload. J Trop Pediatr. 1992; 38(2):64–7.
26.Canatan D, Akdeniz SK. Iron and ferritin levels in saliva of patients with thalassemia and iron deficiency anemia. Mediterr J Hematol Infect Dis. 2012; 4(1):2012051.
27.Xu X, He J, Xue J, Wang Y, Li K, Zhang K, et al. Oral cavity contains distinct niches with dynamic microbial communities. Environ Microbiol. 2015; 17(3):699–710.
28.Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 13(6).
29.Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, Miller W, Kent WJ, Nekrutenko A. “Galaxy: a platform for interactive large-scale genome analysis.” Genome Research. 2005 Oct; 15(10):1451–5.
30.van ‘t Hof W, Veerman EC, Nieuw Amerongen AV, Ligtenberg AJ. Antimicrobial defense systems in saliva. Monogr Oral Sci. 2014; 24:40–51.
31.Mayeur S, Spahis S, Pouliot Y, Levy E. Lactoferrin, a Pleiotropic Protein in Health and Disease. Antioxid Redox Signal. 2016; 24(14):813–36.
32.Farnaud S, Evans RW. Lactoferrin—a multifunctional protein with antimicrobial properties. Mol Immunol. 2003;40(7):395–405.
33.Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie. 2009;91(1):19–29.
34.Latorre M, Quenti D, Travisany D, Singh KV, Murray BE, Maass A, Cambiazo V. The Role of Fur in the Transcriptional and Iron Homeostatic Response of. Front Microbiol. 2018; 9:1580
35.Lisiecki P. Transferrin and Lactoferrin - Human Iron Sources for Enterococci. Pol J Microbiol. 2017; 66(4):419–25.
36.Ford SA, Kao D, Williams D, King KC. Microbe-mediated host defence drives the evolution of reduced pathogen virulence. Nat Commun. 2016; 7:13430.
37.Du RP, Wang Q, Yang YP, Schryvers AB, Chong P, Klein MH, Loosmore SM. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect Immun. 1998 Aug;66(8):3656–65.
38.Beddek AJ, Schryvers AB. The lactoferrin receptor complex in Gram negative bacteria. Biometals. 2010; 23(3):377–86.
39.Minandri F, Imperi F, Frangipani E, Bonchi C, Visaggio D, Facchini M, et al. Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun. 2016;84(8):2324–2335
40.Cornelis P, Dingemans J. Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Cell Infect Microbiol. 2013; 3:75.
41.Llamas MA, Imperi F, Visca P, Lamont IL. Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity. FEMS Microbiol Rev. 2014; 38(4):569–97.
42.Inglis RF, Scanlan P, Buckling A. Iron availability shapes the evolution of bacteriocin resistance in Pseudomonas aeruginosa. ISME J. 2016;10(8):2060–6.
43.Visca P, Imperi F Fau - Lamont IL, Lamont IL. Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol. 2007;15(1):22–30
44.Bruyneel B, Vande Woestyne M, Verstraete W. Lactic acid bacteria: micro-organisms able to grow in the absence of available iron and copper. Biotechnol Lett. 1989; 11(6):401–6.
45.Imbert M, Blondeau R. On the iron requirement of lactobacilli grown in chemically defined medium. Curr Microbiol. 1998; 37(1):64–6.
46.Pandey A, Bringel F, Meyer J-M. Iron requirement and search for siderophores in lactic acid bacteria. Appl Microbiol Biotechno. 1994; 40(5):735–9.
47.Bergqvist SW, Sandberg AS, Andlid T, Wessling-Resnick M. Lactic acid decreases Fe(II) and Fe(III) retention but increases Fe(III) transepithelial transfer by Caco–2 cells. J Agric Food Chem. 2005; 53(17):6919–23.
48.Scheers N, Rossander-Hulthen L, Torsdottir I, Sandberg AS. Increased iron bioavailability from lactic-fermented vegetables is likely an effect of promoting the formation of ferric iron. Eur J Nutr. 2016; 55(1):373–82.
49.Rehncrona S, Hauge HN, Siesjo BK. Enhancement of iron-catalyzed free radical formation by acidosis in brain homogenates: differences in effect by lactic acid and CO2. J Cereb Blood Flow Metab. 1989; 9(1):65–70.
50.Oglesby-Sherrouse AG, Djapgne L, Nguyen AT, Vasil AI, Vasil ML. The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. Pathog Dis. 2014; 70(3):307–20.
51.Gray JW, Pedler SJ. Antibiotic-resistant enterococci. J Hosp Infect. 1992 May;21(1):1–14
52.Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421–33
53.Chevalier S, Bouffartigues E, Bodilis J, Maillot O, Lesouhaitier O, Feuilloley MGJ, et al. Structure, function and regulation of Pseudomonas aeruginosa porins. FEMS Microbiol Rev. 2017; doi: 10.1093/femsre/fux020.
54.Juan C, Torrens G, Gonzalez-Nicolau M, Oliver A. Diversity and regulation of intrinsic beta-lactamases from non-fermenting and other Gram-negative opportunistic pathogens. FEMS Microbiol Rev. 2017; doi: 10.1093/femsre/fux043.
55.Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: Circulation. 2015; doi: 10.1161/CIR.0000000000000296.